These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17828812)

  • 21. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.
    Thimme R; Binder M; Bartenschlager R
    FEMS Microbiol Rev; 2012 May; 36(3):663-83. PubMed ID: 22142141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
    Dharel N; Kato N; Muroyama R; Taniguchi H; Otsuka M; Wang Y; Jazag A; Shao RX; Chang JH; Adler MK; Kawabe T; Omata M
    Hepatology; 2008 Apr; 47(4):1136-49. PubMed ID: 18220274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral regulation and evasion of the host response.
    Loo YM; Gale M
    Curr Top Microbiol Immunol; 2007; 316():295-313. PubMed ID: 17969453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current progress in host innate and adaptive immunity against hepatitis C virus infection.
    Shi J; Li Y; Chang W; Zhang X; Wang FS
    Hepatol Int; 2017 Jul; 11(4):374-383. PubMed ID: 28643186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon signaling in the liver during hepatitis C virus infection.
    Makowska Z; Heim MH
    Cytokine; 2012 Sep; 59(3):460-6. PubMed ID: 22749235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C Virus Stimulates Murine CD8α-Like Dendritic Cells to Produce Type I Interferon in a TRIF-Dependent Manner.
    Pfaender S; Grabski E; Detje CN; Riebesehl N; Lienenklaus S; Steinmann E; Kalinke U; Pietschmann T
    PLoS Pathog; 2016 Jul; 12(7):e1005736. PubMed ID: 27385030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate and Adaptive Immune Responses in Chronic HCV Infection.
    Dustin LB
    Curr Drug Targets; 2017; 18(7):826-843. PubMed ID: 26302811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host-virus interactions in hepatitis B and hepatitis C infection.
    Yoshio S; Kanto T
    J Gastroenterol; 2016 May; 51(5):409-20. PubMed ID: 26894594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-α through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis.
    Chen Y; Jiao B; Yao M; Shi X; Zheng Z; Li S; Chen L
    Virus Res; 2017 Jan; 227():231-239. PubMed ID: 27777077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.
    Zeuzem S; Schmidt JM; Lee JH; Rüster B; Roth WK
    Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatitis C virus (Flaviviridae: Hepacivirus: Hepacivirus C): regulation of signaling reactions of innate immunity].
    Sokolova TM
    Vopr Virusol; 2021 Jan; 65(6):307-316. PubMed ID: 33533227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immunity against hepatitis C virus.
    Xu Y; Zhong J
    Curr Opin Immunol; 2016 Oct; 42():98-104. PubMed ID: 27366996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
    Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
    Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C Virus-Induced Autophagy and Host Innate Immune Response.
    Chan ST; Ou JJ
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28805674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evasion of intracellular host defence by hepatitis C virus.
    Gale M; Foy EM
    Nature; 2005 Aug; 436(7053):939-45. PubMed ID: 16107833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of endogenous type I IFN signaling contributes to persistent HCV infection.
    Li Y; Li S; Duan X; Liu B; Yang C; Zeng P; McGilvray I; Chen L
    Rev Med Virol; 2014 Sep; 24(5):332-42. PubMed ID: 24806972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immune cell networking in hepatitis C virus infection.
    Saha B; Szabo G
    J Leukoc Biol; 2014 Nov; 96(5):757-66. PubMed ID: 25001860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.